Wang Y, Lu J, Chong X, Wang C, Chen X, Peng Z
Signal Transduct Target Ther. 2025; 10(1):100.
PMID: 40082418
PMC: 11906745.
DOI: 10.1038/s41392-025-02193-z.
Li X, Yang F, Wang M, Huang X, Zeng X, Zhou L
Front Pharmacol. 2025; 16:1478331.
PMID: 40078274
PMC: 11897510.
DOI: 10.3389/fphar.2025.1478331.
Imai Y, Otake Y, Tamachi T, Yamane T, Shimao H, Sugihara S
Med Int (Lond). 2025; 5(2):18.
PMID: 39990726
PMC: 11843081.
DOI: 10.3892/mi.2025.217.
Yao K, Zhang S, Zhu B, Sun Y, Tian K, Yan Y
Transl Cancer Res. 2025; 14(1):434-460.
PMID: 39974383
PMC: 11833379.
DOI: 10.21037/tcr-24-1301.
Qu R, Zhang Y, Qin S, Xiong J, Fu X, Li L
Discov Oncol. 2025; 16(1):180.
PMID: 39948247
PMC: 11825439.
DOI: 10.1007/s12672-025-01898-5.
A quantitative spatial cell-cell colocalizations framework enabling comparisons between in vitro assembloids and pathological specimens.
Bouchard G, Zhang W, Ilerten I, Li I, Bhattacharya A, Li Y
Nat Commun. 2025; 16(1):1392.
PMID: 39915493
PMC: 11802768.
DOI: 10.1038/s41467-024-55129-6.
Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance.
Sabit H, Arneth B, Pawlik T, Abdel-Ghany S, Ghazy A, Abdelazeem R
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861138
PMC: 11768313.
DOI: 10.3390/ph18010075.
Extracellular vesicles-a new player in the development of urinary bladder cancer.
Kasinski D, Szeliski K, Drewa T, Pokrywczynska M
Ther Adv Med Oncol. 2025; 17():17588359241297529.
PMID: 39850919
PMC: 11755519.
DOI: 10.1177/17588359241297529.
Estrogen receptor positivity in stromal cells of the tumor bed predicts the response to neoadjuvant chemotherapy for breast carcinoma.
Bayram A, Bagbudar S, Karanlik H, Cabioglu N, Aydiner A, Onder S
Breast Cancer Res Treat. 2025; .
PMID: 39776012
DOI: 10.1007/s10549-024-07601-6.
Visualizing the Tumor Microenvironment: Molecular Imaging Probes Target Extracellular Matrix, Vascular Networks, and Immunosuppressive Cells.
Chan H, Kuo D, Shueng P, Chuang H
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770505
PMC: 11676442.
DOI: 10.3390/ph17121663.
Comparison of diagnostic performance of [Ga]-Ga-FAPI-46 and [F]-FDG PET/CT imaging for the detection of lesions and disease staging in patients with breast cancer.
Radmehr K, Farzanefar S, Abbasi M, Salehi Y, Karamzade-Ziarati N, Emami-Ardekani A
Asia Ocean J Nucl Med Biol. 2025; 13(1):1-9.
PMID: 39744055
PMC: 11682476.
DOI: 10.22038/aojnmb.2024.80845.1573.
Unveiling immune cell response disparities in human primary cancer-associated fibroblasts between two- and three-dimensional cultures.
Yang J, Kulkarni N, Yamaji M, Shiraishi T, Pham T, Do H
PLoS One. 2024; 19(12):e0314227.
PMID: 39700125
PMC: 11658583.
DOI: 10.1371/journal.pone.0314227.
The Two Faces of Angiopoietin-Like Protein 2 in Cancer.
Horiguchi H, Kadomatsu T, Oike Y
Cancer Sci. 2024; 116(3):592-599.
PMID: 39686837
PMC: 11875762.
DOI: 10.1111/cas.16434.
Tumor microenvironment and immunology of cholangiocarcinoma.
Cadamuro M, Fabris L, Zhang X, Strazzabosco M
Hepatoma Res. 2024; 8.
PMID: 39301518
PMC: 11412615.
DOI: 10.20517/2394-5079.2021.140.
The presence of cancer-associated fibroblast in breast cavity side margins is in correlation with the expression of oncoproteins by adjacent epithelial cells: a new era in cancerous potential.
Miripour Z, Aminifar M, Hoseinpour P, Abbasvandi F, Karimi K, Ghahremani A
J Cancer Res Clin Oncol. 2024; 150(9):421.
PMID: 39287633
PMC: 11408549.
DOI: 10.1007/s00432-024-05943-8.
Nuclear lamin A/C phosphorylation by loss of androgen receptor leads to cancer-associated fibroblast activation.
Ghosh S, Isma J, Ostano P, Mazzeo L, Toniolo A, Das M
Nat Commun. 2024; 15(1):7984.
PMID: 39266569
PMC: 11392952.
DOI: 10.1038/s41467-024-52344-z.
Cancer-Associated-Fibroblast-Mediated Paracrine and Autocrine SDF-1/CXCR4 Signaling Promotes Stemness and Aggressiveness of Colorectal Cancers.
Chen C, Yang S, Chang P, Chen S, Nieh S, Huang W
Cells. 2024; 13(16.
PMID: 39195225
PMC: 11352219.
DOI: 10.3390/cells13161334.
Anlotinib inhibits cervical cancer cell proliferation and invasion by suppressing cytokine secretion in activated cancer-associated fibroblasts.
Xiong Y, Xu X, Zhou X, Tong Y, Yu C
Front Oncol. 2024; 14:1412660.
PMID: 39193386
PMC: 11347301.
DOI: 10.3389/fonc.2024.1412660.
METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics.
Jiang J, Liu Y, Qin J, Chen J, Wu J, Pizzi M
Nat Commun. 2024; 15(1):7312.
PMID: 39181865
PMC: 11344794.
DOI: 10.1038/s41467-024-51708-9.
PDPN/CCL2/STAT3 feedback loop alter CAF heterogeneity to promote angiogenesis in colorectal cancer.
Yu D, Xu H, Zhou J, Fang K, Zhao Z, Xu K
Angiogenesis. 2024; 27(4):809-825.
PMID: 39115624
DOI: 10.1007/s10456-024-09941-9.